Lexicon Pharmaceuticals (LXRX) Net Margin Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | 224,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224,487.00 |
| Dec 31, 2025 | -16,097.00 |
| Sep 30, 2025 | 378,262.00 |
| Jun 30, 2025 | 348,069.00 |
| Mar 31, 2025 | 233,031.00 |
| Dec 31, 2024 | 666,407.00 |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2023 | 5.71 Mn |
| Dec 31, 2020 | -217,533.00 |
| Jun 30, 2020 | -27.83 Mn |
| Mar 31, 2020 | 8,917.00 |
| Dec 31, 2019 | -48,766.00 |
| Sep 30, 2019 | 47,025.00 |
| Jun 30, 2019 | -249,917.00 |
| Mar 31, 2019 | -75,837.00 |
| Dec 31, 2018 | -2,079.00 |
| Sep 30, 2018 | -28,227.00 |
| Jun 30, 2018 | 3,853.00 |
| Mar 31, 2018 | 7,660.00 |